RxDoctor Payments Data

Stephanie Phillips

Family · Colquitt, GANPI 1497018840

Payments from drug & device makers

$1,896in general payments, 2019–2025

Across 95 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$453
  • AbbVie$267
  • Dexcom, Inc.$238
  • Lilly USA, LLC$180
  • Boehringer Ingelheim$110
  • Johnson & Johnson$109
  • plus $540 from 16 others

What the payments were for

  • Food & beverage$1,896100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,896 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate74$81,201
MounjaroTirzepatide31$37,326
JardianceEmpagliflozin41$37,061
OzempicSemaglutide23$21,509
LinzessLinaclotide29$21,058
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$11,242
Tresiba Flextouch U-100Insulin Degludec14$10,884
Janumet XrSitagliptin Phos/Metformin Hcl14$10,753
RybelsusSemaglutide11$10,018
EliquisApixaban12$9,485
SymbicortBudesonide/Formoterol Fumarate22$9,149
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$8,374
MitigareColchicine14$6,550
Albuterol Sulfate HfaAlbuterol Sulfate79$3,223
Gabapentin195$2,907

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr$19$91,95488 claims
Lilly USA, LLCMounjaro$180$37,32631 claims
Boehringer IngelheimJardiance$110$37,06141 claims
Novo NordiskOzempic, Rybelsus$453$31,52734 claims
AbbVieLinzess$267$21,05829 claims
AstraZenecaBreztri Aerosphere, Symbicort$93$20,39138 claims
GSKTrelegy Ellipta$51$8,37411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Colquitt

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →